PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of jrsocmedLink to Publisher's site
 
J R Soc Med. 1989 September; 82(9): 571–573.
PMCID: PMC1292317

Malignant mesothelioma.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (776K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Wang NS, Huang SN, Gold P. Absence of carcinoembryonic antigen-like material in mesothelioma: an immunohistochemical differentiation from other lung cancers. Cancer. 1979 Sep;44(3):937–943. [PubMed]
  • Whitaker D, Shilkin KB. Diagnosis of pleural malignant mesothelioma in life--a practical approach. J Pathol. 1984 Jul;143(3):147–175. [PubMed]
  • Corson JM, Pinkus GS. Mesothelioma: profile of keratin proteins and carcinoembryonic antigen: an immunoperoxidase study of 20 cases and comparison with pulmonary adenocarcinomas. Am J Pathol. 1982 Jul;108(1):80–88. [PubMed]
  • Said JW, Nash G, Tepper G, Banks-Schlegel S. Keratin proteins and carcinoembryonic antigen in lung carcinoma: an immunoperoxidase study of fifty-four cases, with ultrastructural correlations. Hum Pathol. 1983 Jan;14(1):70–76. [PubMed]
  • Holden J, Churg A. Immunohistochemical staining for keratin and carcinoembryonic antigen in the diagnosis of malignant mesothelioma. Am J Surg Pathol. 1984 Apr;8(4):277–279. [PubMed]
  • Battifora H, Kopinski MI. Distinction of mesothelioma from adenocarcinoma. An immunohistochemical approach. Cancer. 1985 Apr 15;55(8):1679–1685. [PubMed]
  • Makin CA, Bobrow LG, Bodmer WF. Monoclonal antibody to cytokeratin for use in routine histopathology. J Clin Pathol. 1984 Sep;37(9):975–983. [PMC free article] [PubMed]
  • Twining SS, Brecher AS. Isolation and identification of alpha1-antitrypsin as a component of normal and malignant human breast and other tissues. Proc Soc Exp Biol Med. 1975 Oct;150(1):98–103. [PubMed]
  • Kittas C, Aroni K, Kotsis L, Papadimitriou CS. Distribution of lysozyme, alpha 1-Antichymotrypsin and alpha 1-Antitrypsin in adenocarcinomas of the stomach and large intestine. An immunohistochemical study. Virchows Arch A Pathol Anat Histopathol. 1982;398(2):139–147. [PubMed]
  • Burchell J, Durbin H, Taylor-Papadimitriou J. Complexity of expression of antigenic determinants, recognized by monoclonal antibodies HMFG-1 and HMFG-2, in normal and malignant human mammary epithelial cells. J Immunol. 1983 Jul;131(1):508–513. [PubMed]
  • Heyderman E, Strudley I, Powell G, Richardson TC, Cordell JL, Mason DY. A new monoclonal antibody to epithelial membrane antigen (EMA)-E29. A comparison of its immunocytochemical reactivity with polyclonal anti-EMA antibodies and with another monoclonal antibody, HMFG-2. Br J Cancer. 1985 Sep;52(3):355–361. [PMC free article] [PubMed]
  • Blobel GA, Moll R, Franke WW, Kayser KW, Gould VE. The intermediate filament cytoskeleton of malignant mesotheliomas and its diagnostic significance. Am J Pathol. 1985 Nov;121(2):235–247. [PubMed]
  • Churg A. Immunohistochemical staining for vimentin and keratin in malignant mesothelioma. Am J Surg Pathol. 1985 May;9(5):360–365. [PubMed]
  • Gatter KC, Dunnill MS, Van Muijen GN, Mason DY. Human lung tumours may coexpress different classes of intermediate filaments. J Clin Pathol. 1986 Sep;39(9):950–954. [PMC free article] [PubMed]
  • Lee I, Radosevich JA, Chejfec G, Ma YX, Warren WH, Rosen ST, Gould VE. Malignant mesotheliomas. Improved differential diagnosis from lung adenocarcinomas using monoclonal antibodies 44-3A6 and 624A12. Am J Pathol. 1986 Jun;123(3):497–507. [PubMed]
  • Dewar A, Valente M, Ring NP, Corrin B. Pleural mesothelioma of epithelial type and pulmonary adenocarcinoma: an ultrastructural and cytochemical comparison. J Pathol. 1987 Aug;152(4):309–316. [PubMed]
  • Kwee WS, Veldhuizen RW, Golding RP, Mullink H, Stam J, Donner R, Boon ME. Histologic distinction between malignant mesothelioma, benign pleural lesion and carcinoma metastasis. Evaluation of the application of morphometry combined with histochemistry and immunostaining. Virchows Arch A Pathol Anat Histol. 1982;397(3):287–299. [PubMed]
  • Norton AJ, Thomas JA, Isaacson PG. Cytokeratin-specific monoclonal antibodies are reactive with tumours of smooth muscle derivation. An immunocytochemical and biochemical study using antibodies to intermediate filament cytoskeletal proteins. Histopathology. 1987 May;11(5):487–499. [PubMed]

Articles from Journal of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press